| For: | Gigi E, Lagopoulos V, Liakos A. Management of autoimmune hepatitis induced by hepatitis delta virus. World J Gastroenterol 2024; 30(8): 799-805 [PMID: 38516234 DOI: 10.3748/wjg.v30.i8.799] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i8/799.htm |
| Number | Citing Articles |
| 1 |
Yuting Gao, Yuhang Yin, Pengpeng Xie, Deyu Zhang, Hongyu Li, Xingshun Qi. Interferon in Liver Diseases: Recent Advances. Advances in Therapy 2025; 42(9): 4210 doi: 10.1007/s12325-025-03291-8
|
| 2 |
Chengcheng Wang, Dongting Mao, Yanan Wei, Yanping Fu, Hongsheng Zhang. Clinical Significance and Factors Influencing T-Lymphocyte PD-1/PD-L1, Serum Autoimmune Antibodies and Erythrocyte Distribution Width in Patients with Autoimmune Hepatitis. Hepatitis Monthly 2025; 25(1) doi: 10.5812/hepatmon-161250
|
| 3 |
Markus Cornberg, Fabien Zoulim, Robert Gish, Ira M. Jacobson, Tatyana Kushner, Pietro Lampertico, Mario Rizzetto, Cihan Yurdaydin, Michael Manns. Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines. Antiviral Therapy 2025; 30(4) doi: 10.1177/13596535251349380
|
| 4 |
Mariana Ferreira Cardoso, Henrique Coelho, Joana Carvalho e Branco, Sofia Bragança, Gonçalo Alexandrino, Mariana Nuno Costa, Rita Carvalho, Elizabeth Pádua, Alexandra Martins. Predominance of Genotype 5 Hepatitis Delta Virus Infection in a Portuguese Hepatology Unit. Livers 2024; 4(3): 388 doi: 10.3390/livers4030028
|
